Alcami Announces Enhanced Analytical Services in Edison, New Jersey

Wilmington, NC - September 22, 2016 - Alcami, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, today announces strengthened capabilities in analytical services at its Edison, New Jersey site.

Topics: News & Events Analytical Testing

Embracing Formulation Expertise to Extend Exclusivity & Improve the Patient Experience

Screen_Shot_2016-09-22_at_3.04.09_PM.pngAs published in Pharma's Almanac Q3 2016.

Offering potential exclusivity and access to larger markets, reformulation efforts can prove extremely valuable to both pharmaceutical and biopharmaceutical manufacturers. With reliable CDMO support, this value can be developed in a cost-effective manner and with minimal inconvenience, while reducing the impact of patent loss.

With considerable room for growth in emerging markets, the surge in biopharmaceutical drug development and approvals, as well as merger and acquisition activities that are helping to further existing expertise, has left the pharmaceuticals market poised for growth. At an expected compounded annual growth rate (CAGR) of 4% to 7%, the market is predicted to reach $1.3 trillion in 2018, but challenges still exist as traditional pharmaceuticals are rapidly approaching or have already reached the patent cliff and biopharmaceuticals are beginning to experience competition from biosimilars. 

Topics: Editorials

Alcami Announces Completion of Site Investment and Expansion in Drug Product Manufacturing and Development Facilities

Wilmington, NC - September 8, 2016 - Alcami Corporation, a leading provider of custom manufacturing and development services for the pharmaceutical and biotechnology industries, today announces additional laboratory-scale capabilities to support prefilled syringes in Wilmington, NC and the successful completion of previously announced investments in Charleston, SC.

Topics: News & Events Drug Product Parenteral Manufacturing